SymBio PharmaceuticalsCompany research
Click on headlines below to download research
Treakisym has positive DLBCL results
SymBio Pharmaceuticals | 05/12/2019
On 5 November 2019, SymBio announced it obtained positive results in its pivotal Phase III clinical trial of Treakisym (bendamustine) in patients with…
Treakisym has positive DLBCL results
SymBio Pharmaceuticals | 05/12/2019
On 5 November 2019, SymBio announced it obtained positive results in its pivotal Phase III clinical trial of Treakisym (bendamustine) in patients with…
Guidance sinks on quality control issue
SymBio Pharmaceuticals | 29/08/2019
In an unfortunate turn, SymBio has run into some quality control issues with its shipments of Treakisym from Astellas. During Q219, the company found an…